Pediatric glioblastoma multiforme: A single-institution experience

Indian Journal of Medical and Paediatric Oncology

Volumn 33, Issue 3, 2012, Pages 155-160

  Ansari, Mansour ^a   Nasrolahi, Hamid ^a   Kani, Amir Abbas ^a   Mohammadianpanah, Mohammad ^a   Ahmadloo, Niloofar ^a   Omidvari, Shapour ^a   Mosalaei, Ahmad ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Glioblastoma multiforme; Pediatrics; Survival

Indexed keywords

COBALT; NITROSOUREA; TEMOZOLOMIDE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER SIZE; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; DRUG COST; FEMALE; GENDER; GLIOBLASTOMA; HUMAN; INDIA; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RARE DISEASE; SCHOOL CHILD; SOCIOECONOMICS; STEREOTACTIC BIOPSY; TREATMENT OUTCOME; TUMOR LOCALIZATION;

EID: 84870217653     PISSN: 09715851     EISSN: 09752129     Source Type: Journal    
DOI: 10.4103/0971-5851.103142     Document Type: Article

References (23)

1. Katz DS, Poe LB, Winfield JA, Corona RJ Jr. A rare case of cerebellar glioblastoma multiforme in childhood: MR imaging. Clin Imaging 1995;19: 162-4.
2. Adamson C, Kanu OO, Mehta AI, Di C, Lin N, Mattox AK, et al. Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs 2009;18: 1061-83.
3. Sathornsumetee S, Rich JN. New treatment strategies for malignant gliomas. Expert Rev Anticancer Ther 2006;6: 1087-104.
4. Noda SE, El-Jawahri A, Patel D, Lautenschlaeger T, Siedow M, Chakravarti A. Molecular advances of brain tumors in radiation oncology. Semin Radiat Oncol 2009;19: 171-8.
5. Robins HI, Chang S, Butowski N, Mehta M. Therapeutic advances for glioblastoma multiforme: current status and future prospects. Curr Oncol Rep 2007;9: 66-70.
6. Borgo MC, Pereira JL, Lima FB, Brandão RA, Carvalho GT, Costa BS. Glioblastoma multiforme in childhood: a case report. Clinics (Sao Paulo) 2010;65: 923-5.
7. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5: 649-55.
8. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, et al. Long-term survival with glioblastoma multiforme. Brain 2007;130: 2596-606.
9. Filippini G, Falcone C, Boiardi A, Broggi G, Bruzzone MG, Caldiroli D, et al. Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro Oncol 2008;10: 79-87.
10. Sánchez-Herrera F, Castro-Sierra E, Gordillo-Domínguez LF, Vaca-Ruiz MA, Santana-Montero B, Perezpeña-Diazconti M, et al. Glioblastoma multiforme in children: experience at Hospital Infantil de Mexico Federico Gomez. Childs Nerv Syst 2009;25: 551-7.
11. Dohrmann GJ, Farwell JR, Flannery JT. Glioblastoma multiforme in children. J Neurosurg 1976;44: 442-8.
12. Suri V, Das P, Pathak P, Jain A, Sharma MC, Borkar SA, et al. Pediatric glioblastomas: A histopathological and molecular genetics study. Neuro Oncol 2009;11: 274-80.
13. Perkins SM, Rubin JB, Leonard JR, Smyth MD, El Naqa I, Michalski JM, et al. Glioblastoma in children: A single institution experience. Int J Radiat Oncol Biol Phys 2011;80: 1117-21.
14. Marchese MJ, Chang CH. Malignant astrocytic gliomas in children. Cancer 1990;65: 2771-8.
15. Piroth MD, Gagel B, Pinkawa M, Stanzel S, Asadpour B, Eble MJ. Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors. Strahlenther Onkol 2007;183: 695-702.
16. Robins HI, Chang S, Butowski N, Mehta M. Therapeutic advances for glioblastoma multiforme: current status and future prospects. Curr Oncol Rep 2007;9: 66-70.
17. Buckner JC, Brown PD, O'Neill BP, Meyer FB, Wetmore CJ, Uhm JH. Central nervous system tumors. Mayo Clin Proc 2007;82: 1271-86.
18. Shinoda J, Sakai N, Murase S, Yano H, Matsuhisa T, Funakoshi T. Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection. J Neurooncol 2001;52: 161-71.
19. Odrazka K, Petera J, Kohlova T, Dolezel M, Vaculikova M, Zouhar M, et al. Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma. Strahlenther Onkol 2003;179: 615-9.
20. McGirt MJ, Mukherjee D, Chaichana KL, Than KD, Weingart JD, Quinones-Hinojosa A. Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery 2009; 65: 463-9.
21. Villavicencio AT, Burneikiene S, Romanelli P, Fariselli L, McNeely L, Lipani JD, et al. Survival following stereotactic radiosurgery for newly diagnosed and recurrent glioblastoma multiforme: A multicenter experience. Neurosurg Rev 2009;32: 417-24.
22. Li SW, Qiu XG, Chen BS, Zhang W, Ren H, Wang ZC, et al. Prognostic factors influencing clinical outcomes of glioblastoma multiforme. Chin Med J (Engl) 2009; 122: 1245-9.
23. Grovas AC, Boyett JM, Lindsley K, Rosenblum M, Yates AJ, Finlay JL. Regimen-related toxicity of myeloablative chemotherapy with BCNU, thiotepa, and etoposide followed by autologous stem cell rescue for children with newly diagnosed glioblastoma multiforme: Report from the Children's Cancer Group. Med Pediatr Oncol 1999; 33: 83-7.